MusclePharm Strengthens Management Team Adding John H. Bluher as COO and EVP

DENVER, Sept. 20, 2011 /PRNewswire/ -- MusclePharm Corporation (OTCBB: MSLP), an expanding U.S. nutritional supplement company ("MusclePharm" or the "Company"), is pleased to announce John H. Bluher has been named Chief Operating Officer and Executive Vice President for MusclePharm Corporation ("MSLP"). In announcing the new appointment, MusclePharm CEO Brad Pyatt said, "As COO, John brings us exceptional depth and balance. His broad range of experience with public companies, boards and financial structuring in addition to mergers and acquisitions will prove helpful as we are positioning MusclePharm for continued growth and profitability in 2012. He has proven abilities to realize the potential of an organization while rationalizing operational cost. We are extremely excited about how John will contribute to the further strengthening of MusclePharm's leadership position and growth prospects."

Mr. Bluher will immediately join the Executive Committee and the MSLP Board of Directors in October 2011. As COO, he reports to Mr. Pyatt and has responsibility for functional management and day-to-day operations. His long-range goals are to help with budgeting, managing MSLPs capital structure, structure departments as the company grows, develop control processes, and assist in developing supply chain management and inventory controls. Working closely with Mr. Bluher, Mr. Pyatt will now have time to focus on longer-range strategies, business development, extending the branding and marketing opportunities for MusclePharm.  Finance, Legal, Operations, Investor Relations, Public Relations, and Administration report to Mr. Bluher.  Mr. Bluher has been working as a consultant to MSLP for the past three months.

Mr. Bluher said: "I am excited for the opportunity to come into MusclePharm at such an important time for this young company. The company is growing at a tremendous pace and with the brand recognition accelerating, Brad felt that he needed someone focused full time on the internal controls, budgets, and financial and capital requirements of the company.  Brad has aggressively built the brand and grown the company with innovative products, I will be focusing on building on his success so we can provide a return to our equity investors."

Mr. Bluher has significant experience working with corporate structuring, corporate boards and committees, risk management, and public company corporate governance. He has 20 years of experience working in financial services public companies as Chief Legal Officer, General Counsel, Director of Risk, and Chief Compliance Officer. Most recently he was Chief Legal Officer at Neuberger Berman and managed the sale of this company out of the Lehman Brothers estate. He was also General Counsel of the Investment Management Division of Lehman Brothers, Inc. His experience also includes negotiating transactions and purchases, and sales of assets and properties on a global basis. He has deep experience in creating and implementing corporate governance plans, working in the corporate board room, and as director of risk, developing internal audit programs and insurance programs for public companies.

He has served on the boards of ICI Mutual Insurance Company, the NASDAQ Chairman's Advisory Board, Cherry Hills Founders Group, Inc., and the University of Wyoming, College of Law Advisory Board. Mr. Bluher is currently on the Board of Targeted Medical Pharma, Inc., Safe Communications, Inc. and University of Wyoming Foundation Board.  

About MusclePharm Corporation

Headquartered in Denver, Colorado, MusclePharm is a healthy life-style company that develops and manufactures a full line of NSF and Informed Choice approved nutritional supplements that are free of banned substances.  Based on years of research at the MusclePharm Sports Science Center, the products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts, and Major League Baseball.  The Company's products address all categories of an active lifestyle, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen.  MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe, and Vitamin World.  MusclePharm products are also sold in over 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com.  For more information, please visit www.musclepharm.com.

Forward Looking Statements

The information contained herein includes forward-looking statements.  These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.  Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity.  We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

PR Contact:
Annette Dallavalle
5W Public Relations
(212) 584-4299
[email protected]

SOURCE MusclePharm Corporation